Get started
Author

Esther García-Gil

Observed names: E Garcia-Gil, Esther Garcia-Gil
Institution: Almirall (Spain)
ORCID: 0000-0002-1530-3173
Observed ORCID: 0000-0002-1530-3173
OpenAlex ID: A5006619671
GOLD assessment of COPD severity in the Clinical Practice Research Datalink (CPRD)
2018 · Cristina Rebordosa, Estel Plana, et al. · Pharmacoepidemiology and Drug Safety · 27
The efficacy of aclidinium/formoterol on lung function and symptoms in patients with COPD categorized by symptom status: a pooled analysis
2016 · Marc Miravitlles, Kenneth Chapman, et al. · International Journal of COPD · 20
A Phase III Study Evaluating Aclidinium Bromide, a Novel Long-Acting Antimuscarinic, in Patients with COPD: ACCLAIM/COPD I.
2009 · PW Jones, A Agusti, et al. · American Journal of Respiratory and Critical Care Medicine · 7
Use of aclidinium did not increase the risk of death in a noninterventional cohort study in the Clinical Practice Research Datalink (CPRD), United Kingdom
2019 · Cristina Rebordosa, Jaume Aguado, et al. · Respiratory Medicine · 6
Aclidinium bromide, a novel long-acting muscarinic antagonist (LAMA)
2010 · Amadeu Gavaldà, Esther Garcia-Gil · Progress in respiratory research/Progress in research in emphysema and chronic bronchitis/Progress in respiration research · 4
Efficacy and safety of aclidinium/formoterol versus monotherapies and aclidinium versus placebo in Chinese and other Asian patients with moderate-to-severe COPD: The AVANT Phase 3 study
2023 · Yongchang Sun, Eduard Molins, et al. · Respiratory Medicine · 2
PDF
The Pharmacokinetics, Safety and Tolerability of Aclidinium Bromide 400 μg Administered by Inhalation as Single and Multiple (Twice Daily) Doses in Healthy Chinese Participants
2023 · Weimin Li, Sami Daoud, et al. · International Journal of COPD · 1
PDF
71146 Beyond the Face: Treating Truncal Acne with Sarecycline - a Multinational Phase 3 Pooled Analysis
2026 · James Q. Del Rosso, Jianzhong Zhang, et al. · Journal of the American Academy of Dermatology
An Evaluation of the Pharmacokinetics, Safety, and Tolerability of Aclidinium/Formoterol Fixed-Dose Combination Administered in Chinese Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease
2022 · Hong Zhang, Sami Z. Daoud, et al. · Drugs in R&D
PDF
The Impact of Exacerbation History on the Safety and Efficacy of Aclidinium in Patients with Chronic Obstructive Pulmonary Disease and Increased Cardiovascular Risk: ASCENT-COPD Trial
2021 · Robert A Wise, Kenneth R Chapman, et al. · International Journal of COPD
PDF
AMPLIFY: efficacy of aclidinium vs tiotropium in COPD
2018 · Sanjay Sethi, Edward Kerwin, et al. · European Respiratory Journal
The missing puff: Results of multiple imputation of PPFEV1 in CPRD
2018 · Cristina Rebordosa Garcia, Susana Perez‐Gutthann, et al. · Pharmacoepidemiology and Drug Safety
Works count: 12
Citation count: 67
H-index: 4
I10-index: 2
Year
Topic
Type